U.S. flag

An official website of the United States government

NM_022458.4(LMBR1):c.-183GCT[1] AND not provided

Germline classification:
Benign (1 submission)
Last evaluated:
Jul 15, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001653721.2

Allele description [Variation Report for NM_022458.4(LMBR1):c.-183GCT[1]]

NM_022458.4(LMBR1):c.-183GCT[1]

Genes:
LOC129999727:ATAC-STARR-seq lymphoblastoid silent region 18853 [Gene]
LMBR1:limb development membrane protein 1 [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
7q36.3
Genomic location:
Preferred name:
NM_022458.4(LMBR1):c.-183GCT[1]
HGVS:
  • NC_000007.14:g.156893171AGC[1]
  • NG_009240.2:g.5033GCT[1]
  • NM_001350953.2:c.-183GCT[1]
  • NM_001350954.2:c.-322GCT[1]
  • NM_001350955.2:c.-815GCT[1]
  • NM_001350956.2:c.-717GCT[1]
  • NM_001350957.2:c.-650GCT[1]
  • NM_001350958.2:c.-717GCT[1]
  • NM_001363409.2:c.-183GCT[1]
  • NM_001363410.2:c.-183GCT[1]
  • NM_001363411.2:c.-650GCT[1]
  • NM_001363412.2:c.-173GCT[1]
  • NM_001363413.2:c.-835GCT[1]
  • NM_022458.4:c.-183GCT[1]MANE SELECT
  • NC_000007.13:g.156685865AGC[1]
  • NM_022458.3:c.-180_-178delGCT
  • NR_146958.2:n.8GCT[1]
  • NR_146959.2:n.8GCT[1]
Links:
dbSNP: rs370780340
NCBI 1000 Genomes Browser:
rs370780340
Molecular consequence:
  • NM_001350953.2:c.-183GCT[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001350954.2:c.-322GCT[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001350955.2:c.-815GCT[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001350956.2:c.-717GCT[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001350957.2:c.-650GCT[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001350958.2:c.-717GCT[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001363409.2:c.-183GCT[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001363410.2:c.-183GCT[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001363411.2:c.-650GCT[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001363412.2:c.-173GCT[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001363413.2:c.-835GCT[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_022458.4:c.-183GCT[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NR_146958.2:n.8GCT[1] - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_146959.2:n.8GCT[1] - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001864211GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)		Benign
(Jul 15, 2018) 		germlineclinical testing

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV001864211.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 17, 2024